PE20221407A1 - Formas solidas de n-ter-butil-4[(2-(5-cloro-2-hidroxi-fenil)acetil)amino]piridin-2-carboxamida - Google Patents
Formas solidas de n-ter-butil-4[(2-(5-cloro-2-hidroxi-fenil)acetil)amino]piridin-2-carboxamidaInfo
- Publication number
- PE20221407A1 PE20221407A1 PE2022000136A PE2022000136A PE20221407A1 PE 20221407 A1 PE20221407 A1 PE 20221407A1 PE 2022000136 A PE2022000136 A PE 2022000136A PE 2022000136 A PE2022000136 A PE 2022000136A PE 20221407 A1 PE20221407 A1 PE 20221407A1
- Authority
- PE
- Peru
- Prior art keywords
- carboxamide
- acetyl
- pyridine
- chloro
- tert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1910664.0A GB201910664D0 (en) | 2019-07-25 | 2019-07-25 | Novel forms of compound |
| PCT/GB2020/051779 WO2021014167A1 (en) | 2019-07-25 | 2020-07-24 | Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phneyl)acetyl]amino]pyridine-2-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20221407A1 true PE20221407A1 (es) | 2022-09-20 |
Family
ID=67990591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2022000136A PE20221407A1 (es) | 2019-07-25 | 2020-07-24 | Formas solidas de n-ter-butil-4[(2-(5-cloro-2-hidroxi-fenil)acetil)amino]piridin-2-carboxamida |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US12281077B2 (https=) |
| EP (1) | EP4003960A1 (https=) |
| JP (1) | JP7627683B2 (https=) |
| KR (1) | KR20220087430A (https=) |
| CN (1) | CN114585607B (https=) |
| AU (1) | AU2020318943A1 (https=) |
| BR (1) | BR112022001276A2 (https=) |
| CA (1) | CA3145285A1 (https=) |
| CL (1) | CL2022000187A1 (https=) |
| CO (1) | CO2022002046A2 (https=) |
| CR (2) | CR20220079A (https=) |
| GB (1) | GB201910664D0 (https=) |
| IL (1) | IL290071B1 (https=) |
| MX (1) | MX2022000891A (https=) |
| MY (1) | MY207877A (https=) |
| PE (1) | PE20221407A1 (https=) |
| PH (1) | PH12022550193A1 (https=) |
| UA (1) | UA129300C2 (https=) |
| WO (1) | WO2021014167A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050176767A1 (en) * | 2003-10-30 | 2005-08-11 | Laval Chan Chun Kong | Pyridine carboxamide and methods for inhibiting HIV integrase |
| CA2658362A1 (en) | 2006-06-29 | 2008-01-03 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors |
| WO2016042114A1 (en) * | 2014-09-19 | 2016-03-24 | F. Hoffmann-La Roche Ag | Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis |
| US11358947B2 (en) | 2017-04-17 | 2022-06-14 | The Regents Of The University Of California | Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A |
| GB201801355D0 (en) * | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
-
2019
- 2019-07-25 GB GBGB1910664.0A patent/GB201910664D0/en not_active Ceased
-
2020
- 2020-07-24 MY MYPI2022000419A patent/MY207877A/en unknown
- 2020-07-24 WO PCT/GB2020/051779 patent/WO2021014167A1/en not_active Ceased
- 2020-07-24 CN CN202080053826.8A patent/CN114585607B/zh active Active
- 2020-07-24 PE PE2022000136A patent/PE20221407A1/es unknown
- 2020-07-24 PH PH1/2022/550193A patent/PH12022550193A1/en unknown
- 2020-07-24 JP JP2022505329A patent/JP7627683B2/ja active Active
- 2020-07-24 AU AU2020318943A patent/AU2020318943A1/en active Pending
- 2020-07-24 KR KR1020227006247A patent/KR20220087430A/ko active Pending
- 2020-07-24 EP EP20751235.1A patent/EP4003960A1/en active Pending
- 2020-07-24 IL IL290071A patent/IL290071B1/en unknown
- 2020-07-24 MX MX2022000891A patent/MX2022000891A/es unknown
- 2020-07-24 CA CA3145285A patent/CA3145285A1/en active Pending
- 2020-07-24 CR CR20220079A patent/CR20220079A/es unknown
- 2020-07-24 UA UAA202200857A patent/UA129300C2/uk unknown
- 2020-07-24 CR CR20250316A patent/CR20250316A/es unknown
- 2020-07-24 BR BR112022001276A patent/BR112022001276A2/pt unknown
-
2022
- 2022-01-24 CL CL2022000187A patent/CL2022000187A1/es unknown
- 2022-01-24 US US17/582,539 patent/US12281077B2/en active Active
- 2022-02-25 CO CONC2022/0002046A patent/CO2022002046A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3145285A1 (en) | 2021-01-28 |
| GB201910664D0 (en) | 2019-09-11 |
| IL290071B1 (en) | 2026-02-01 |
| AU2020318943A1 (en) | 2022-03-17 |
| JP2022542918A (ja) | 2022-10-07 |
| BR112022001276A2 (pt) | 2022-03-22 |
| JP7627683B2 (ja) | 2025-02-06 |
| KR20220087430A (ko) | 2022-06-24 |
| PH12022550193A1 (en) | 2023-01-09 |
| MX2022000891A (es) | 2022-05-26 |
| EP4003960A1 (en) | 2022-06-01 |
| US20220220074A1 (en) | 2022-07-14 |
| US12281077B2 (en) | 2025-04-22 |
| CN114585607B (zh) | 2025-11-14 |
| CL2022000187A1 (es) | 2022-10-07 |
| CO2022002046A2 (es) | 2022-06-10 |
| CR20220079A (es) | 2022-06-28 |
| CR20250316A (es) | 2025-08-27 |
| UA129300C2 (uk) | 2025-03-12 |
| CN114585607A (zh) | 2022-06-03 |
| IL290071A (en) | 2022-03-01 |
| WO2021014167A1 (en) | 2021-01-28 |
| MY207877A (en) | 2025-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024003027A (es) | Forma cristalina del compuesto heterociclico de pirimidina y metodo de preparacion del mismo. | |
| PE20211478A1 (es) | Formas cristalinas novedosas | |
| BRPI0514372A (pt) | inibidores de tiazol de frutose 1, 6-bisfosfatase | |
| IL286218A (en) | Solid state forms of ripretinib | |
| DK3774817T3 (da) | Bcl6-hæmmere | |
| AR121018A1 (es) | Forma en estado sólido de piroxasulfona | |
| HN2011002408A (es) | Nueva forma cristalina vi de la agomelatina, preparacion y uso de la misma. | |
| AR110768A1 (es) | Formas cristalinas de tenofovir alafenamida | |
| IL289453A (en) | Process for the preparation of ridinilazole and crystalline forms thereof | |
| MX2021007505A (es) | Síntesis de 3-metil-1,2,4-tiadiazol-5-carbohidrazida o de su forma deuterada con metil-d3. | |
| IL288348A (en) | Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereof | |
| PT3908584T (pt) | Formas cristalinas de 1-(1,2-dimetilpropil)-n-etil-5- metil-n-piridazin-4-il-pirazol-4-carboxamida | |
| AR104935A1 (es) | Formas cristalinas de un inhibidor de histona deacetilasa | |
| DK3816164T5 (da) | Isothiazolo[5,4-d]pyrimidin-forbindelse som irak4-inhibitor | |
| EP3980440A4 (en) | Anti-inflammatory agents | |
| DK3774844T3 (da) | Krystallinske dipeptider, der er anvendelige i syntese af elamipretid | |
| EP4291180A4 (en) | Crystalline 5-methoxy-dipropyl tryptamine compounds | |
| PE20221407A1 (es) | Formas solidas de n-ter-butil-4[(2-(5-cloro-2-hidroxi-fenil)acetil)amino]piridin-2-carboxamida | |
| EP4534007A4 (en) | FIXING TOOL | |
| EP3840937A4 (en) | GENERATION OF COLORED OBJECTS | |
| IL314730A (en) | Crystalline (+)-tetrabenazine | |
| EP4105017C0 (de) | Dünnsteinerzeugnis | |
| IT201900016532A1 (it) | Processo per la preparazione di una nanospugna | |
| EP4039407A4 (en) | TOOL MAGAZINE | |
| IL312099A (en) | Novel crystalline forms |